DST and melanoma: Next, in order to address the therapeutic relevance of this finding, we tested whether the pharmacological inhibition of FAK1 (FAKi) could specifically affect the tumor growth in mice subcutaneously injected with melanoma cells derived from BPA−/− (sBPA−/−) tumors (Fig. 5k).